Authorized Shares and Capital. The authorized capital stock and the issued and outstanding capital stock of the Company is as set forth in the SEC Reports.
Authorized Shares and Capital. The authorized capital stock of the Company is comprised of 10,000,000,000 shares of Common Stock and 50,000,000 shares of preferred stock, par value $0.0001 per share (the “Preferred Stock”). 200,000 shares of the Preferred Stock has been designated as the Series A Preferred Stock of the Company (the “Series A Stock”). As of the Effective Date, there are 25,872,504 shares of Common Stock issued and outstanding, and 35,520 shares of Series A Stock issued and outstanding, and there are no issued or outstanding Derivatives to acquire any shares of capital stock of the Company.
Authorized Shares and Capital. SRM’s authorized number of common shares issued and outstanding is two (2) (“Common Stock”). The issued and outstanding shares of Common Stock are validly issued, fully paid, and non-assessable and not issued in violation of the preemptive or other rights of any person. No Person has any right of first refusal, preemptive right, right of participation, or any similar right to participate in the transactions contemplated by the Transaction Documents. Except as a result of the purchase and sale of the Securities and except as set forth on Schedule 1.02, there are no outstanding options, warrants, scrip rights to subscribe to, calls or commitments of any character whatsoever relating to, or securities, rights or obligations convertible into or exercisable or exchangeable for, or giving any Person any right to subscribe for or acquire any shares of SRM Common Stock, or contracts, commitments, understandings or arrangements by which the Company or any Subsidiary is or may become bound to issue additional shares of SRM Common Stock or SRM Common Stock Equivalents as hereinafter defined. The term “SRM Common Stock Equivalents” means any securities of SRM which would entitle the holder thereof to acquire at any time SRM Common Stock, including, without limitation, any debt, preferred stock, right, option, warrant or other instrument that is at any time convertible into or exercisable or exchangeable for, or otherwise entitles the holder thereof to receive SRM Common Stock. The Exchange will not obligate SRM to issue shares of SRM Common Stock or other securities to any Person (other than the Company) and will not result in a right of any holder of SRM’s securities to adjust the exercise, conversion, exchange or reset price under any of such securities. All of the outstanding shares of capital stock of SRM are duly authorized, validly issued, fully paid and nonassessable, have been issued in compliance with all federal and state securities laws, and none of such outstanding shares was issued in violation of any preemptive rights or similar rights to subscribe for or purchase securities. Other than approval by the Board of Directors of BBIG, no further approval or authorization of any other party is required for the completion of the Exchange. There are no stockholders’ agreements, voting agreements or other similar agreements with respect to SRM’s capital stock to which the Company is a party or, to the knowledge of SRM, between or among any of SRM’s stockholders. ...
Authorized Shares and Capital. BioModeling has 50,000,000 shares of common stock, no par value, authorized (the “BioModeling Common Stock”) with 12,425,000 shares issued and outstanding. The shares of BioModeling Common Stock outstanding are validly issued, fully paid, and non-assessable and not issued in violation of the preemptive or other rights of any person.
Authorized Shares and Capital. Vivos has 10,000,000 shares of common stock, no par value and 5,000,000 preferred shares, no par value, authorized (the “Vivos Common Stock”) with 5,000 common shares and nil preferred shares issued and outstanding. The shares of Vivos Common Stock outstanding are validly issued, fully paid, and non-assessable and not issued in violation of the preemptive or other rights of any person.
Authorized Shares and Capital. (a) The authorized capital stock of Magiclytics consists of (i) 5,000 shares of common stock, par value $0.01 per share, of which 5,000 shares are issued and outstanding and (ii) no shares of preferred stock. All of the issued and outstanding Magiclytics Shares are held, collectively, by the Magiclytics Shareholders.
Authorized Shares and Capital. (a) The authorized capital stock of Acquired Company consists of (i) 200,000 shares of Class A Common Stock, par value $0.01 per share, of which 181,034 shares are issued and outstanding and (ii) 4,800,000 shares of Class B Common Stock, par value $0.01 per share, of which 2,298,669.860 shares are issued and outstanding. All of the issued and outstanding Acquired Shares are held, collectively, by the Sellers. Schedule 3.05(a) sets forth a true, correct and complete list of all the authorized issued and outstanding shares of the Company’s capital stock and/or other securities of the Company including the Acquired Shares and the name of each holder thereof and the amount and type of capital stock and/or other securities of the Company held by such Person.
Authorized Shares and Capital. (a) As of the Effective Date, the authorized capital stock of the Company consists of (i) 500,000,000 shares of common stock, par value $0.001 per share, and (ii) 50,000,000 shares of preferred stock, par value $0.001 per share (the “Preferred Stock”), of which no shares are designated, issued or outstanding, provided that this representation in this clause (ii) shall be deemed automatically updated upon the completion of the items as set forth in Section 6.05.
Authorized Shares and Capital. (a) The authorized capital stock of Eagle Lake consists of 10,000,000 shares of common stock, no stated par value per share, of which 10,000,000 shares are issued and outstanding. All of the issued and outstanding Eagle Lake Stock is held, collectively, by the Eagle Lake Shareholders.
Authorized Shares and Capital. The authorized number of common shares with $0.001 par value of PFH is 90,000,000 with 11,411,512 shares issued and outstanding. The issued and outstanding shares are validly issued, fully paid, and non-assessable and not issued in violation of the preemptive or other rights of any person. PFH is authorized to issue 10,000,000 shares of preferred stock, $0.001 par value, none of which are issued and outstanding.
